FDA.reportPublic FDA data

Chamois Glide

Manufacturer
W STERNOFF LLC
Effective date
2009-12-06
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:22:52

Label at a glance#

ProductChamois Glide
Active ingredientALLANTOIN
Label structure10 sections

Indications and uses

helps prevent and helps relieve chafed, chapped or cracked skin helps protect from the drying effects of wind and cold weather temporarily protects minor cuts, scrapes, burns

Dosage and administration

Apply as needed.

Label contents#

Full prescribing information#

Active Ingredient: 

DESCRIPTION SECTION

Allantoin 0.5%

Purpose

DESCRIPTION SECTION

Skin Protectant

Uses

INDICATIONS & USAGE SECTION

  • helps prevent and helps relieve chafed, chapped or cracked skin
  • helps protect from the drying effects of wind and cold weather
  • temporarily protects minor cuts, scrapes, burns

Warnings

WARNINGS SECTION

For external use only.

When using this product

OTC - WHEN USING SECTION

  • do not get into eyes

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • condition worsens
  • symptoms last more than 7 days or clear up and occur again within a few days

Do not use on

SPL UNCLASSIFIED SECTION

  • deep or puncture wounds
  • animal bites
  • serious burns

Keep out of reach of children. If swallowed, get medical help or contact Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply as needed.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

aloe barbadensis leaf juice, C18-36 acid triglyceride, capric/caprylic triglycerides, fragrance, yellow 11 (CI 47000), green 6 (CI 61565), tocopheryl acetate, tribehenin

Questions +1 425.467.6580

Distributor: Bodyglide, Bellevue, WA USA

© 2009 W Sternoff LLC Made in Canada

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

minty fresh

new endurance formula

apply directly to skin, shorts, chamois
stop saddle sores™

No messy cream

No greasy butter

invisible

no water

no lanolin

no petroleum

no mineral oil

reliable since 1996

apply once

ride longer

NET WT. 0.45 oz (12.8 g)

Principal Display Panel minty fresh new endurance formula apply directly to skin, shorts, chamois stop saddle sores™ No messy cream No greasy butter invisible no water no lanoli...Principal Display Panel minty fresh new endurance formula apply directly to skin, shorts, chamois stop saddle sores™ No messy cream No greasy butter invisible no water no lanoli...

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1044541allantoin 0.5 % Topical OintmentPSN1
1044961Chamois Glide 0.5 % Topical StickPSN1
1044961allantoin 0.005 MG/MG Topical Ointment [Chamois Glide]SBD1
1044541allantoin 0.005 MG/MG Topical OintmentSCD1
1044541allantoin 0.5 % Topical StickSY1
1044961Chamois Glide 0.005 MG/MG Topical OintmentSY1
1044961Chamois Glide 0.5 % Topical OintmentSY1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
15197-008-142019-10-21C16284748780-1956f9ecf-d4e5-621f-e053-dbdaa90a74adChamois Glide
15197-008-262019-10-21C16284748780-1956f9ecf-d4e5-621f-e053-dbdaa90a74adChamois Glide
15197-008-462019-10-21C16284748780-1956f9ecf-d4e5-621f-e053-dbdaa90a74adChamois Glide

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
15197-008-13Chamois Glide36.9 g in 1 TUBESTICK36.91
15197-008-14Chamois Glide1 in 1 PACKAGESTICK11
15197-008-25Chamois Glide70 g in 1 TUBESTICK701
15197-008-26Chamois Glide1 in 1 PACKAGESTICK11
15197-008-45Chamois Glide12.8 g in 1 TUBESTICK12.81
15197-008-46Chamois Glide1 in 1 PACKAGESTICK11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
15197-008CHAMOIS GLIDE (ALLANTOIN) STICK [W STERNOFF LLC]1Legacy NDC, 6 package rows20091203_4189b99e-c5c2-4e37-a8a7-2c7c73397c24.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ALLANTOINACTIVE INGREDIENT344S277G0Z1
ALLANTOINACTIVE MOIETY344S277G0Z1
.ALPHA.-TOCOPHEROL ACETATE, D-INACTIVE INGREDIENTA7E6112E4N1
ALOE VERA LEAFINACTIVE INGREDIENTZY81Z83H0X1
D&C GREEN NO. 6INACTIVE INGREDIENT4QP5U84YF71
D&C YELLOW NO. 11INACTIVE INGREDIENT44F3HYL9541
MEDIUM-CHAIN TRIGLYCERIDESINACTIVE INGREDIENTC9H2L21V7U1
TRIBEHENININACTIVE INGREDIENT8OC9U7TQZ01

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
15197-00815197-008-13, 15197-008-14, 15197-008-25, 15197-008-26, 15197-008-45, 15197-008-46

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Name, UNII, Kind table
NameUNIIKind
ALLANTOIN344S277G0ZACTIB
ALOE VERA LEAFZY81Z83H0XIACT
D&C YELLOW NO. 1144F3HYL954IACT
D&C GREEN NO. 64QP5U84YF7IACT
.ALPHA.-TOCOPHEROL ACETATE, D-A7E6112E4NIACT
TRIBEHENIN8OC9U7TQZ0IACT
MEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UIACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 18 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UINJECTION, EMULSION / INTRAVENOUS1.1 %w/vExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UPOWDER / SUBLINGUAL2 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7USUSPENSION / ORAL10170 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7ULOTION / TOPICAL7 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UCAPSULE / ORAL4771 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7USOLUTION / ORAL5566 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7USPRAY / TOPICAL540 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UOINTMENT / TOPICAL20 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UFILM, EXTENDED RELEASE / TRANSDERMALNAExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UINJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS990.3 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UTABLET / ORAL2 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UCREAM / TOPICAL3300 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UTABLET, ORALLY DISINTEGRATING / ORAL1 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UTABLET, EXTENDED RELEASE / ORAL0.37 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UGEL / TOPICAL12 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UPOWDER, FOR SUSPENSION / ORAL3390 mg/5mlExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7USPRAY, METERED / SUBLINGUAL110 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UAEROSOL, FOAM / TOPICAL10.87 %w/wExact identifier — unii candidate
18 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
7f61b268-213a-469d-9014-4cfcf13467794189b99e-c5c2-4e37-a8a7-2c7c73397c242009-12-06WarningsExact identifier
spl id: 7f61b268-213a-469d-9014-4cfcf1346779
spl set id: 4189b99e-c5c2-4e37-a8a7-2c7c73397c24

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.